+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

  • ID: 5118597
  • Report
  • June 2020
  • Region: Global
  • 190 pages
  • GMD Research
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer Healthcare
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Heska Co.
  • Novartis International AG
  • MORE
Global active pharmaceutical ingredients (API) market will reach $293.5 billion by 2026, growing by 7.2% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.

Highlighted with 91 tables and 99 figures, this 190-page report “Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.

Synthetic API
  • Branded Synthetic API
  • Generic Synthetic API
Biotech API by Drug Type:
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Other Biotech APIs
Biotech API by Customer Base:
  • Innovative Biologic API
  • Generic Biosimilar API
Biotech API by Expression Technology:
  • Mammalian Expression
  • Microbial Expression
  • Yeast Expression
  • Insect Expression
  • Other Expression Technologies
HPAPI
  • Branded HPAPI
  • Generic HPAPI
Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.

Captive Manufacturing
  • Branded Captive API
  • Generic Captive API
Merchant Manufacturing by Drug Type:
  • Branded Merchant API
  • Generic Merchant API
Merchant Manufacturing by Drug Synthesis:
  • Merchant Synthetic API
  • Merchant Biotech API
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Pulmonary Disorders
  • Orthopedics
  • Other Applications
Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • RoW (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global API market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • Bayer Healthcare
  • Bioniche Animal Health
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Ceva Animal Health, Inc.
  • Elanco Animal Health
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Heska Co.
  • Lonza Group
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Ranbaxy Laboratories
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Bayer Healthcare
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Heska Co.
  • Novartis International AG
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Global Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Customer Base
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI

4 Segmentation of Global Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API

5 Segmentation of Global Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications

6 Segmentation of Global Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs

7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2019-2026
7.2 North America Market 2019-2026 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2019-2026 by Country
7.3.1 Overview of European Market
7.3.2 UK
7.3.3 France
7.3.4 Germany
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2019-2026 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 Australia
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2019-2026 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 Rest of World Market 2019-2026 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • Bayer Healthcare
  • Bioniche Animal Health
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Ceva Animal Health, Inc.
  • Elanco Animal Health
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Heska Co.
  • Lonza Group
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Ranbaxy Laboratories
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market, 2019-2026
Table 2. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market
Table 3. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 4. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2015-2026, $ bn
Table 5. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2015-2026, $ bn
Table 6. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Customer Base, 2015-2026, $ bn
Table 7. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2015-2026, $ bn
Table 8. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2015-2026, $ bn
Table 9. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 10. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2015-2026, $ bn
Table 11. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2015-2026, $ bn
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2015-2026, $ bn
Table 13. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 14. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2015-2026, $ bn
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Region, 2015-2026, $ bn
Table 16. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 17. Leading National Active Pharmaceutical Ingredients (API) Market, 2019 and 2026, $ bn
Table 18. North America Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn
Table 19. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 20. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 21. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 22. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 23. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 24. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 25. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 26. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 27. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 28. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn
Table 29. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 30. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 31. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 32. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 33. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 34. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 35. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 36. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 37. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 38. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 39. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 40. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 41. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 42. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 43. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 44. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 45. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 46. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 47. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2015-2026, $ bn
Table 48. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn
Table 49. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 50. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 51. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 52. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 53. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 54. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 55. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 56. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 57. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 58. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 59. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 60. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 61. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 62. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 63. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 64. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2015-2026, $ bn
Table 65. South America Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn
Table 66. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 67. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 68. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 69. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 70. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 71. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 72. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 73. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 74. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 75. RoW Active Pharmaceutical Ingredients (API) Market by Country, 2015-2026, $ bn
Table 76. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 77. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 78. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 79. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 80. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 81. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 82. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2015-2026, $ bn
Table 83. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2015-2026, $ bn
Table 84. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2015-2026, $ bn
Table 85. AbbVie Inc.: Company Snapshot
Table 86. AbbVie Inc.: Business Segmentation
Table 87. AbbVie Inc.: Product Portfolio
Table 88. AbbVie Inc.: Revenue, 2016-2018, $ bn
Table 89. AbbVie Inc.: Recent Developments
Table 90. Risk Evaluation for Investing in Global Market, 2019-2026
Table 91. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026
Figure 5. Global Active Pharmaceutical Ingredients (API) Market, 2019-2026, $ bn
Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 7. GDP per capita in the World, 1960-2018, $ thousand
Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 9. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Five Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market
Figure 12. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2019-2026, % of Revenue
Figure 13. Contribution to Global 2020-2026 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 14. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2015-2026, $ bn
Figure 15. Global Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2015-2026, $ bn
Figure 16. Global Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2015-2026, $ bn
Figure 17. Global Active Pharmaceutical Ingredients (API) Market: Biotech API, 2015-2026, $ bn
Figure 18. Global Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2015-2026, $ bn
Figure 19. Global Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2015-2026, $ bn
Figure 20. Global Active Pharmaceutical Ingredients (API) Market: Vaccines, 2015-2026, $ bn
Figure 21. Global Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2015-2026, $ bn
Figure 22. Global Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2015-2026, $ bn
Figure 23. Global Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2015-2026, $ bn
Figure 24. Global Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2015-2026, $ bn
Figure 25. Global Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2015-2026, $ bn
Figure 26. Global Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2015-2026, $ bn
Figure 27. Global Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2015-2026, $ bn
Figure 28. Global Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2015-2026, $ bn
Figure 29. Global Active Pharmaceutical Ingredients (API) Market: HPAPI, 2015-2026, $ bn
Figure 30. Global Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2015-2026, $ bn
Figure 31. Global Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2015-2026, $ bn
Figure 32. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2019-2026, % of Revenue
Figure 33. Contribution to Global 2020-2026 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 34. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2015-2026, $ bn
Figure 35. Global Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2015-2026, $ bn
Figure 36. Global Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2015-2026, $ bn
Figure 37. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2015-2026, $ bn
Figure 38. Global Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2015-2026, $ bn
Figure 39. Global Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2015-2026, $ bn
Figure 40. Global Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2015-2026, $ bn
Figure 41. Global Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2015-2026, $ bn
Figure 42. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2019-2026, % of Revenue
Figure 43. Contribution to Global 2020-2026 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 44. Global Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2015-2026, $ bn
Figure 45. Global Active Pharmaceutical Ingredients (API) Market: Oncology, 2015-2026, $ bn
Figure 46. Global Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2015-2026, $ bn
Figure 47. Global Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2015-2026, $ bn
Figure 48. Global Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2015-2026, $ bn
Figure 49. Global Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2015-2026, $ bn
Figure 50. Global Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2015-2026, $ bn
Figure 51. Global Active Pharmaceutical Ingredients (API) Market: Other Applications, 2015-2026, $ bn
Figure 52. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2019-2026, % of Revenue
Figure 53. Contribution to Global 2020-2026 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 54. Global Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2015-2026, $ bn
Figure 55. Global Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2015-2026, $ bn
Figure 56. Global Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2015-2026, $ bn
Figure 57. Global Market Snapshot by Region
Figure 58. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2019-2026, % of Revenue
Figure 59. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value ($ bn) and Share (%)
Figure 60. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 61. North American Active Pharmaceutical Ingredients (API) Market, 2015-2026, $ bn
Figure 62. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2019 and 2026, % of Revenue
Figure 63. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 64. U.S. Active Pharmaceutical Ingredients (API) Market, 2015-2026, $ bn
Figure 65. Canada Active Pharmaceutical Ingredients (API) Market, 2015-2026, $ bn
Figure 66. Active Pharmaceutical Ingredients (API) Market in Mexico, 2015-2026, $ bn
Figure 67. European Active Pharmaceutical Ingredients (API) Market, 2015-2026, $ bn
Figure 68. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2019 and 2026, % of Revenue
Figure 69. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 70. Active Pharmaceutical Ingredients (API) Market in UK, 2015-2026, $ bn
Figure 71. Active Pharmaceutical Ingredients (API) Market in France, 2015-2026, $ bn
Figure 72. Active Pharmaceutical Ingredients (API) Market in Germany, 2015-2026, $ bn
Figure 73. Active Pharmaceutical Ingredients (API) Market in Spain, 2015-2026, $ bn
Figure 74. Active Pharmaceutical Ingredients (API) Market in Italy, 2015-2026, $ bn
Figure 75. Active Pharmaceutical Ingredients (API) Market in Russia, 2015-2026, $ bn
Figure 76. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2015-2026, $ bn
Figure 77. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2015-2026, $ bn
Figure 78. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2019 and 2026, % of Revenue
Figure 79. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 80. Active Pharmaceutical Ingredients (API) Market in China, 2015-2026, $ bn
Figure 81. Active Pharmaceutical Ingredients (API) Market in Japan, 2015-2026, $ bn
Figure 82. Active Pharmaceutical Ingredients (API) Market in India, 2015-2026, $ bn
Figure 83. Active Pharmaceutical Ingredients (API) Market in Australia, 2015-2026, $ bn
Figure 84. Active Pharmaceutical Ingredients (API) Market in South Korea, 2015-2026, $ bn
Figure 85. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2015-2026, $ bn
Figure 86. South America Active Pharmaceutical Ingredients (API) Market, 2015-2026, $ bn
Figure 87. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2019 and 2026, % of Revenue
Figure 88. Contribution to South America 2020-2026 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 89. Active Pharmaceutical Ingredients (API) Market in Argentina, 2015-2026, $ bn
Figure 90. Active Pharmaceutical Ingredients (API) Market in Brazil, 2015-2026, $ bn
Figure 91. Active Pharmaceutical Ingredients (API) Market in Chile, 2015-2026, $ bn
Figure 92. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2015-2026, $ bn
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of the World (RoW), 2015-2026, $ bn
Figure 94. Breakdown of RoW Active Pharmaceutical Ingredients (API) Market by Country, 2019 and 2026, % of Revenue
Figure 95. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 96. Active Pharmaceutical Ingredients (API) Market in UAE, 2015-2026, $ bn
Figure 97. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2015-2026, $ bn
Figure 98. Active Pharmaceutical Ingredients (API) Market in South Africa, 2015-2026, $ bn
Figure 99. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Note: Product cover images may vary from those shown
3 of 4
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • Bayer Healthcare
  • Bioniche Animal Health
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Ceva Animal Health, Inc.
  • Elanco Animal Health
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline PLC
  • Heska Co.
  • Lonza Group
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Ranbaxy Laboratories
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll